Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.
Advertisement
The Importance of Diversity in Clinical Trials for Hepatitis C
Featured Content
article
Steps to Diagnosing and Getting Treatment for Hep C
What to expect during and after hep C screening and how to decide on a treatment plan.
article
Why Hepatitis C is Called a "Quiet Killer"
Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.
article
How to Emotionally Support Someone with Hep C
Learn simple and appreciated ways to help someone cope with hepatitis C.
article
Hep C Treatment for Patients on Medicaid
A look at some of the challenges people insured through Medicaid may face when seeking treatment for hep C.